The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107010318 10701031 8 F 2008 20160815 20150109 20160819 EXP US-009507513-1204USA03734 MERCK 0.00 M Y 97.96000 KG 20160819 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107010318 10701031 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, QD 20788 1 MG FILM-COATED TABLET QD
107010318 10701031 2 SS PROSCAR FINASTERIDE 1 Oral CUT INTO 1/4; 1.25 MG, QD U 0 1.25 MG FILM-COATED TABLET QD
107010318 10701031 3 SS FINASTERIDE. FINASTERIDE 1 1 MG, UNK 0 1 MG TABLET
107010318 10701031 4 SS FINASTERIDE. FINASTERIDE 1 5 MG, UNK 0 5 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107010318 10701031 1 Alopecia
107010318 10701031 2 Alopecia
107010318 10701031 3 Alopecia

Outcome of event

Event ID CASEID OUTC COD
107010318 10701031 OT
107010318 10701031 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
107010318 10701031 Adverse event
107010318 10701031 Anxiety
107010318 10701031 Arthritis
107010318 10701031 Asthenia
107010318 10701031 Breast tenderness
107010318 10701031 Cognitive disorder
107010318 10701031 Depression
107010318 10701031 Drug ineffective
107010318 10701031 Ejaculation disorder
107010318 10701031 Ejaculation failure
107010318 10701031 Erectile dysfunction
107010318 10701031 Fatigue
107010318 10701031 Haemorrhoid operation
107010318 10701031 Hormone level abnormal
107010318 10701031 Hot flush
107010318 10701031 Hypercholesterolaemia
107010318 10701031 Hypogonadism
107010318 10701031 Insomnia
107010318 10701031 Intentional product misuse
107010318 10701031 Libido decreased
107010318 10701031 Limb injury
107010318 10701031 Memory impairment
107010318 10701031 Muscle atrophy
107010318 10701031 Panic attack
107010318 10701031 Patellofemoral pain syndrome
107010318 10701031 Penile size reduced
107010318 10701031 Product use issue
107010318 10701031 Psychosexual disorder
107010318 10701031 Rectal polypectomy
107010318 10701031 Semen discolouration
107010318 10701031 Sexual dysfunction
107010318 10701031 Skin graft
107010318 10701031 Testicular atrophy
107010318 10701031 Tympanoplasty

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107010318 10701031 1 20081113 20090725 0
107010318 10701031 2 2008 2011 0
107010318 10701031 3 2009 2011 0
107010318 10701031 4 20091030 20111205 0